Table of contents
Volume 92, Issue 8
Published online 20 April 2005 (1341-1590)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letter to the Editor
Minireview
State-of-the-art management of locally advanced head and neck cancer FREE
T Y Seiwert and E E W Cohen
Br J Cancer 92: 1341-1348; doi:10.1038/sj.bjc.6602510
Clinical Studies
Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis FREE
M Mohren, I Markmann, K Jentsch-Ullrich, M Koenigsmann, G Lutze and A Franke
Br J Cancer 92: 1349-1351; advance online publication, March 29, 2005; doi:10.1038/sj.bjc.6602504
Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma FREE
M Ng, J Waters, D Cunningham, I Chau, A Horwich, M Hill, A R Norman, A Wotherspoon and D Catovsky
Br J Cancer 92: 1352-1357; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602514
Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma FREE
K Pritchard-Jones, I Spendlove, C Wilton, J Whelan, S Weeden, I Lewis, J Hale, C Douglas, C Pagonis, B Campbell, P Alvarez, G Halbert and L G Durrant
Br J Cancer 92: 1358-1365; advance online publication, March 29, 2005; doi:10.1038/sj.bjc.6602500
Histopathologic indicators of breast cancer biology: insights from population mammographic screening FREE
L R Webster, A M Bilous, L Willis, K Byth, F C Burgemeister, E L C Salisbury, C L Clarke and R L Balleine
Br J Cancer 92: 1366-1371; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602501
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer FREE
D D Stocken, M W Büchler, C Dervenis, C Bassi, H Jeekel, J H G Klinkenbijl, K E Bakkevold, T Takada, H Amano and J P Neoptolemos on behalf of the Pancreatic Cancer Meta-analysis Group
Br J Cancer 92: 1372-1381; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602513
Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma FREE
C-K Toh, D Heng, Y-K Ong, S-S Leong, J Wee and E-H Tan
Br J Cancer 92: 1382-1387; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602525
HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions FREE
M C G Bleeker, J Berkhof, C J A Hogewoning, F J Voorhorst, A J C van den Brule, T M Starink, P J F Snijders and C J L M Meijer
Br J Cancer 92: 1388-1392; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602524
The use of denial in an ethnically diverse British cancer population: a cross-sectional study FREE
R Roy, R P Symonds, D M Kumar, K Ibrahim, A Mitchell and L Fallowfield
Br J Cancer 92: 1393-1397; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602523
Lack of clinical efficacy of imatinib in metastatic melanoma FREE
S Ugurel, R Hildenbrand, A Zimpfer, P La Rosée, P Paschka, A Sucker, P Keikavoussi, J C Becker, W Rittgen, A Hochhaus and D Schadendorf
Br J Cancer 92: 1398-1405; doi:10.1038/sj.bjc.6602529
Translational Therapeutics
Elucidation of the tumoritropic principle of hypericin FREE
M Van de Putte, T Roskams, J R Vandenheede, P Agostinis and P A M de Witte
Br J Cancer 92: 1406-1413; doi:10.1038/sj.bjc.6602512
Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery FREE
Y Wang, Z Yang, S Liu, T Kon, A Krol, C-Y Li and F Yuan
Br J Cancer 92: 1414-1420; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602494
Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct FREE
A Roth, F Rohrbach, R Weth, B Frisch, F Schuber and W S Wels
Br J Cancer 92: 1421-1429; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602526
HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo FREE
L Pukac, P Kanakaraj, R Humphreys, R Alderson, M Bloom, C Sung, T Riccobene, R Johnson, M Fiscella, A Mahoney, J Carrell, E Boyd, X T Yao, L Zhang, L Zhong, A von Kerczek, L Shepard, T Vaughan, B Edwards, C Dobson, T Salcedo and V Albert
Br J Cancer 92: 1430-1441; doi:10.1038/sj.bjc.6602487
The development and characterisation of porphyrin isothiocyanate–monoclonal antibody conjugates for photoimmunotherapy FREE
R Hudson, M Carcenac, K Smith, L Madden, O J Clarke, A Pèlegrin, J Greenman and R W Boyle
Br J Cancer 92: 1442-1449; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602517
Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naïve T-cell priming FREE
A Merrick, F Errington, K Milward, D O'Donnell, K Harrington, A Bateman, H Pandha, R Vile, E Morrison, P Selby and A Melcher
Br J Cancer 92: 1450-1458; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602518
Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells FREE
D J A de Groot, T Timmer, D C J Spierings, T K P Le, S de Jong and E G E de Vries
Br J Cancer 92: 1459-1466; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602516
Molecular Diagnostics
Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival FREE
S-B Catrina, M Lewitt, C Massambu, A Dricu, J Grünler, M Axelson, P Biberfeld and K Brismar
Br J Cancer 92: 1467-1474; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602408
Ascites induces modulation of 
6
1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma FREE
N Ahmed, C Riley, K Oliva, G Rice and M Quinn
Br J Cancer 92: 1475-1485; advance online publication, March 29, 2005; doi:10.1038/sj.bjc.6602495
Altered expression of topoisomerase II contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation FREE
T Asano, K Nakamura, H Fujii, N Horichi, T Ohmori, K Hasegawa, T Isoe, M Adachi, N Otake and Y Fukunaga
Br J Cancer 92: 1486-1492; advance online publication, March 29, 2005; doi:10.1038/sj.bjc.6602498
Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium FREE
R L Adams, I P Adams, S W Lindow, W Zhong and S L Atkin
Br J Cancer 92: 1493-1498; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602503
Flexible, actin-based ridges colocalise with the 1 integrin on the surface of melanoma cells FREE
K Poole and D Müller
Br J Cancer 92: 1499-1505; doi:10.1038/sj.bjc.6602515
Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells FREE
E Hofsli, L Thommesen, F Yadetie, M Langaas, W Kusnierczyk, U Falkmer, A K Sandvik and A Laegreid
Br J Cancer 92: 1506-1516; doi:10.1038/sj.bjc.6602535
Microsatellite instability in patients with chronic B-cell lymphocytic leukaemia FREE
E Niv, Y Bomstein, M Yuklea and M Lishner
Br J Cancer 92: 1517-1523; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602532
Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients FREE
M M I Hussien, H McNulty, N Armstrong, P G Johnston, R A J Spence and Y Barnett
Br J Cancer 92: 1524-1530; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602530
Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone FREE
S E Aldridge, T W J Lennard, J R Williams and M A Birch
Br J Cancer 92: 1531-1537; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602417
Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer FREE
H Koike, K Ito, Y Takezawa, T Oyama, H Yamanaka and K Suzuki
Br J Cancer 92: 1538-1544; doi:10.1038/sj.bjc.6602520
Absence of a specific radiation signature in post-Chernobyl thyroid cancers FREE
V Detours, S Wattel, D Venet, N Hutsebaut, T Bogdanova, M D Tronko, J E Dumont, B Franc, G Thomas and C Maenhaut
Br J Cancer 92: 1545-1552; advance online publication, April 5, 2005; doi:10.1038/sj.bjc.6602521
Genetics and Genomics
Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells FREE
L-J Henderson, B P Coe, E H L Lee, L Girard, A F Gazdar, J D Minna, S Lam, C MacAulay and W L Lam
Br J Cancer 92: 1553-1560; advance online publication, March 22, 2005; doi:10.1038/sj.bjc.6602452
Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy FREE
A D Santin, F Zhan, S Cane', S Bellone, M Palmieri, M Thomas, A Burnett, J J Roman, M J Cannon, J Shaughnessy Jr and S Pecorelli
Br J Cancer 92: 1561-1573; advance online publication, March 22, 2005; doi:10.1038/sj.bjc.6602480
Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour FREE
D Astuti, F Latif, K Wagner, D Gentle, W N Cooper, D Catchpoole, R Grundy, A C Ferguson-Smith and E R Maher
Br J Cancer 92: 1574-1580; advance online publication, March 29, 2005; doi:10.1038/sj.bjc.6602478
Gastrin stabilises -catenin protein in mouse colorectal cancer cells FREE
D H Song, J C Kaufman, L Borodyansky, C Albanese, R G Pestell and M Michael Wolfe
Br J Cancer 92: 1581-1587; advance online publication, March 29, 2005; doi:10.1038/sj.bjc.6602509
Letter to the Editor
Can a rational design for metronomic chemotherapy dosing be devised? FREE
A Maraveyas, T Lam, J W Hetherington and J Greenman
Br J Cancer 92: 1588-1590; doi:10.1038/sj.bjc.6602474
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
